Polypeptide Innovations: Advancements in Delivery and Targeting for Precision Medicine
暫譯: 多肽創新：精準醫療的遞送與標靶技術進展
Abdellatif, Ahmed Ah
- 出版商: CRC
- 出版日期: 2026-10-16
- 售價: $8,990
- 貴賓價: 9.5 折 $8,540
- 語言: 英文
- 頁數: 276
- 裝訂: Hardcover - also called cloth, retail trade, or trade
- ISBN: 1041100698
- ISBN-13: 9781041100690
尚未上市，無法訂購
商品描述
Polypeptides are essential biomolecules for physiological and therapeutic purposes, and this book addresses the complex relationships between polypeptides and biological systems. It examines transport and targeting processes to reveal the latest polypeptide precision medicine advances. A complete overview of polypeptides and their creative medical uses, particularly in distribution, targeting, and therapy is presented, as well as polypeptides' fundamental ideas and nanomedicine innovations which are important in biological processes and therapeutics. An extensive list of references and case studies provides the readers with additional resources to deepen their knowledge on the subject.
- Addresses the complex relationships between polypeptides and biological systems.
- This unique text can be used on pharmacology, medicinal chemistry, and biomedical engineering courses, providing the latest research and case studies.
- Provides a complete guide to polypeptide synthesis and formulations and their applications in disease treatment.
- Essential for business training programs that teach cutting-edge science and companies investing in nanotechnology and biomedical research.
- Covers the latest research and clinical trials, making it a valuable resource for researchers, clinicians, and students
商品描述(中文翻譯)
多肽是生理與治療用途不可或缺的生物分子。本書探討多肽與生物系統之間的複雜關係，並檢視運輸與標靶 प्रक्र程，以呈現多肽精準醫療的最新進展。本書完整概述多肽及其創新的醫學用途，尤其著重於分布、標靶與治療；同時介紹多肽的基本概念，以及在生物過程與治療領域中相當重要的奈米醫學創新。書中亦提供豐富的參考文獻與案例研究，為讀者深入了解此主題提供額外資源。
• 探討多肽與生物系統之間的複雜關係。
• 本書內容獨具特色，適用於藥理學、藥物化學與生物醫學工程課程，並提供最新研究成果與案例研究。
• 提供多肽合成、製劑配方及其在疾病治療中應用的完整指南。
• 適合教授尖端科學的企業培訓課程，也適合投入奈米科技與生物醫學研究的企業。
• 涵蓋最新研究與臨床試驗，是研究人員、臨床醫師與學生的重要參考資源。
作者簡介
Ahmed AH Abdellatif is a highly experienced expert in the field of Pharmaceutics and Pharmaceutical Technology, with over 22 years of experience in basic research and new dosage form formulation. He holds a Ph.D. in Pharmaceutical Technology from the University of Regensburg in Germany, and during his time there, he worked at the Institute of Chemistry and Pharmacy. Abdellatif has extensive knowledge of the synthesis of different types of nanoparticles, including metal and polymeric nanoparticles, coupled with his experience in the characterization of nanoparticles, chemical synthesis, cell biology, and biotechnological methods, make him an ideal candidate for anyone seeking to develop innovative solutions with nanoparticles that can revolutionize the field of nanotechnology. Abdellatif' has experience in developing nanoparticles and that each step of the process, from synthesis to characterization. This level of meticulousness is evident in his work, as he has authored or co-authored more than 100 publications, demonstrating a deep understanding of the latest advancements in formulation of new dosage, nanobiotechnology, chemical synthesis, cell biology, and receptor targeting. Currently, Abdellatif works as a Professor in the Department of Pharmaceutics at the College of Pharmacy at Qassim University. He continues to develop his skills and knowledge in the field and is excited to bring his expertise to any team seeking to develop new and innovative solutions with nanoparticles. Throughout his career, Abdellatif has demonstrated a passion for educating future generations of scientists and researchers. His work has focused on developing innovative solutions to common problems in the field, such as improving the bioavailability of drugs and enhancing drug delivery systems. His research has also explored the potential of nanoparticle-based therapeutics in treating a variety of diseases, including cancer and infectious diseases. Abdellatif's work in the field of nanotechnology has the potential to revolutionize the way we approach drug delivery and treatment. By developing innovative solutions with nanoparticles, he is helping to pave the way for safer, more effective therapies that can improve patient outcomes and save lives.
作者簡介(中文翻譯)
Ahmed AH Abdellatif 是藥劑學（Pharmaceutics）與製藥技術領域經驗豐富的專家，擁有超過 22 年的基礎研究與新劑型開發經驗。他在德國雷根斯堡大學取得製藥技術博士學位，並曾於該校化學與藥學研究所任職。
Abdellatif 精通多種類型奈米粒子的合成，包括金屬奈米粒子與聚合物奈米粒子；此外，他在奈米粒子特性分析、化學合成、細胞生物學及生物技術方法方面也具備豐富經驗。這些專業能力使他成為協助開發奈米粒子創新應用的理想人選，相關技術有望為奈米科技領域帶來革命性的突破。
Abdellatif 具備奈米粒子開發經驗，涵蓋從合成到特性分析的每一個步驟。他對研究流程的嚴謹態度充分展現在其學術成果中；截至目前為止，他已獨立或共同發表超過 100 篇論文，展現出對新劑型開發、奈米生物技術、化學合成、細胞生物學及受體標靶技術最新進展的深入理解。
目前，Abdellatif 任職於 Qassim University 藥學院藥劑學系，擔任教授。他持續精進自己在該領域的技能與知識，並樂於將其專業經驗投入任何致力於開發奈米粒子創新解決方案的團隊。
在整個職業生涯中，Abdellatif 始終致力於培育新一代科學家與研究人員。他的研究工作聚焦於解決該領域的常見問題，例如提升藥物的生體可用率，以及改善藥物傳遞系統。他的研究也探討以奈米粒子為基礎的治療方式，在治療包括癌症與感染性疾病等多種疾病上的潛力。
Abdellatif 在奈米科技領域的研究，有望徹底改變藥物傳遞與治療的方式。透過開發以奈米粒子為基礎的創新解決方案，他正協助為更安全、更有效的療法奠定基礎，進而改善病患治療成效並拯救生命。
